D. E. Shaw & Co., Inc. Codex Dna, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $67,158 - $93,231	39,505 New	39,505 $66,000
Q4 2021 Feb 14, 2022	SELL	$6.31 - $11.96 $125,852 - $238,542	-19,945 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.15 - $19.88 $202,441 - $396,506	19,945 New	19,945 $222,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.